147 related articles for article (PubMed ID: 21185312)
21. Disruption of ShcA signaling halts cell proliferation--characterization of ShcC residues that influence signaling pathways using yeast.
Heinrich JN; Kwak SP; Howland DS; Chen J; Sturner S; Sullivan K; Lipinski K; Cheng KY; She Y; Lo F; Ghavami A
Cell Signal; 2006 Jun; 18(6):795-806. PubMed ID: 16126371
[TBL] [Abstract][Full Text] [Related]
22. Prediction of binding sites of peptide recognition domains: an application on Grb2 and SAP SH2 domains.
McLaughlin WA; Hou T; Wang W
J Mol Biol; 2006 Apr; 357(4):1322-34. PubMed ID: 16476443
[TBL] [Abstract][Full Text] [Related]
23. Wiskott-Aldrich syndrome protein is associated with the adapter protein Grb2 and the epidermal growth factor receptor in living cells.
She HY; Rockow S; Tang J; Nishimura R; Skolnik EY; Chen M; Margolis B; Li W
Mol Biol Cell; 1997 Sep; 8(9):1709-21. PubMed ID: 9307968
[TBL] [Abstract][Full Text] [Related]
24. Grb2 and its apoptotic isoform Grb3-3 associate with heterogeneous nuclear ribonucleoprotein C, and these interactions are modulated by poly(U) RNA.
Romero F; Ramos-Morales F; Domínguez A; Rios RM; Schweighoffer F; Tocqué B; Pintor-Toro JA; Fischer S; Tortolero M
J Biol Chem; 1998 Mar; 273(13):7776-81. PubMed ID: 9516488
[TBL] [Abstract][Full Text] [Related]
25. Solution structure of the Grb2 SH2 domain complexed with a high-affinity inhibitor.
Ogura K; Shiga T; Yokochi M; Yuzawa S; Burke TR; Inagaki F
J Biomol NMR; 2008 Nov; 42(3):197-207. PubMed ID: 18830565
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of Grb2 SH2 Domain Proteins for Mirror-Image Screening Systems.
Noguchi T; Ishiba H; Honda K; Kondoh Y; Osada H; Ohno H; Fujii N; Oishi S
Bioconjug Chem; 2017 Feb; 28(2):609-619. PubMed ID: 28032751
[TBL] [Abstract][Full Text] [Related]
27. Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases.
Honma M; Higuchi O; Shirakata M; Yasuda T; Shibuya H; Iemura S; Natsume T; Yamanashi Y
Genes Cells; 2006 Feb; 11(2):143-51. PubMed ID: 16436051
[TBL] [Abstract][Full Text] [Related]
28. Structure-based design and synthesis of phosphinate isosteres of phosphotyrosine for incorporation in Grb2-SH2 domain inhibitors. Part 2.
Walker CV; Caravatti G; Denholm AA; Egerton J; Faessler A; Furet P; García-Echeverría C; Gay B; Irving E; Jones K; Lambert A; Press NJ; Woods J
Bioorg Med Chem Lett; 2000 Oct; 10(20):2343-6. PubMed ID: 11055352
[TBL] [Abstract][Full Text] [Related]
29. Grb2 binding to the different isoforms of Ret tyrosine kinase.
Alberti L; Borrello MG; Ghizzoni S; Torriti F; Rizzetti MG; Pierotti MA
Oncogene; 1998 Sep; 17(9):1079-87. PubMed ID: 9764818
[TBL] [Abstract][Full Text] [Related]
30. A recombined fusion protein PTD-Grb2-SH2 inhibits the proliferation of breast cancer cells in vitro.
Yin J; Cai Z; Zhang L; Zhang J; He X; Du X; Wang Q; Lu J
Int J Oncol; 2013 Mar; 42(3):1061-9. PubMed ID: 23314696
[TBL] [Abstract][Full Text] [Related]
31. Structure-based design of compounds inhibiting Grb2-SH2 mediated protein-protein interactions in signal transduction pathways.
Fretz H; Furet P; Garcia-Echeverria C; Schoepfer J; Rahuel J
Curr Pharm Des; 2000 Dec; 6(18):1777-96. PubMed ID: 11102562
[TBL] [Abstract][Full Text] [Related]
32. Tight association of GRB2 with receptor protein-tyrosine phosphatase alpha is mediated by the SH2 and C-terminal SH3 domains.
den Hertog J; Hunter T
EMBO J; 1996 Jun; 15(12):3016-27. PubMed ID: 8670803
[TBL] [Abstract][Full Text] [Related]
33. Specificity and affinity motifs for Grb2 SH2-ligand interactions.
Kessels HW; Ward AC; Schumacher TN
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8524-9. PubMed ID: 12084912
[TBL] [Abstract][Full Text] [Related]
34. Selective GRB2 SH2 inhibitors as anti-Ras therapy.
Gay B; Suarez S; Caravatti G; Furet P; Meyer T; Schoepfer J
Int J Cancer; 1999 Oct; 83(2):235-41. PubMed ID: 10471533
[TBL] [Abstract][Full Text] [Related]
35. SH3-mediated targeting of Wrch1/RhoU by multiple adaptor proteins.
Risse SL; Vaz B; Burton MF; Aspenström P; Piekorz RP; Brunsveld L; Ahmadian MR
Biol Chem; 2013 Mar; 394(3):421-32. PubMed ID: 23183748
[TBL] [Abstract][Full Text] [Related]
36. Dimerization of the adaptor Gads facilitates antigen receptor signaling by promoting the cooperative binding of Gads to the adaptor LAT.
Sukenik S; Frushicheva MP; Waknin-Lellouche C; Hallumi E; Ifrach T; Shalah R; Beach D; Avidan R; Oz I; Libman E; Aronheim A; Lewinson O; Yablonski D
Sci Signal; 2017 Sep; 10(498):. PubMed ID: 28951535
[TBL] [Abstract][Full Text] [Related]
37. UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug.
Oneyama C; Nakano H; Sharma SV
Oncogene; 2002 Mar; 21(13):2037-50. PubMed ID: 11960376
[TBL] [Abstract][Full Text] [Related]
38. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.
Vogel W; Ullrich A
Cell Growth Differ; 1996 Dec; 7(12):1589-97. PubMed ID: 8959326
[TBL] [Abstract][Full Text] [Related]
39. Targeting the Interaction between the SH3 Domain of Grb2 and Gab2.
Malagrinò F; Coluccia A; Bufano M; Regina G; Puxeddu M; Toto A; Visconti L; Paone A; Magnifico MC; Troilo F; Cutruzzolà F; Silvestri R; Gianni S
Cells; 2020 Nov; 9(11):. PubMed ID: 33171874
[TBL] [Abstract][Full Text] [Related]
40. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
